Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

PubWeight™: 9.12‹?› | Rank: Top 0.1%

🔗 View Article (PMID 11124987)

Published in J Neurosci on December 15, 2000

Authors

J E Malberg1, A J Eisch, E J Nestler, R S Duman

Author Affiliations

1: Laboratory of Molecular Psychiatry, Departments of Psychiatry and Pharmacology, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, Connecticut 06508, USA.

Articles citing this

(truncated to the top 100)

New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci (2010) 8.09

The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiatry Clin Neurosci (2005) 7.21

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron (2009) 5.20

Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature (2011) 5.17

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry (2008) 4.06

TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron (2008) 4.00

Hippocampal and amygdalar volumes in dissociative identity disorder. Am J Psychiatry (2006) 3.64

Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A (2006) 3.39

Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A (2001) 3.01

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry (2007) 2.93

It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol (2007) 2.85

Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron (2013) 2.74

Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology (2009) 2.63

Social isolation delays the positive effects of running on adult neurogenesis. Nat Neurosci (2006) 2.52

Adult-born hippocampal neurons are more numerous, faster maturing, and more involved in behavior in rats than in mice. J Neurosci (2009) 2.51

The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci (2004) 2.43

The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol (2010) 2.42

Experience-driven brain plasticity: beyond the synapse. Neuron Glia Biol (2004) 2.27

Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22

Exercise and the brain: something to chew on. Trends Neurosci (2009) 2.20

Experience dictates stem cell fate in the adult hippocampus. Neuron (2011) 2.18

Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry (2003) 2.16

Adult neurogenesis and the olfactory system. Prog Neurobiol (2009) 2.12

Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry (2011) 2.11

Development of neural stem cell in the adult brain. Curr Opin Neurobiol (2008) 2.02

5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol (2009) 1.99

An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice. Sci Transl Med (2014) 1.99

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest (2005) 1.94

Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology (2010) 1.87

Adult neurogenesis: integrating theories and separating functions. Trends Cogn Sci (2010) 1.83

Depression and hippocampal neurogenesis: a road to remission? Science (2012) 1.81

Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry (2011) 1.81

The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80

Regulation and function of adult neurogenesis: from genes to cognition. Physiol Rev (2014) 1.79

Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci (2013) 1.79

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets (2006) 1.78

Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci Biobehav Rev (2008) 1.77

Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol (2012) 1.71

Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry (2008) 1.67

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci (2005) 1.67

Effects of adult-generated granule cells on coordinated network activity in the dentate gyrus. Hippocampus (2010) 1.67

Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry (2011) 1.65

Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression. Biol Psychiatry (2015) 1.63

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology (2010) 1.61

Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes. J Recept Signal Transduct Res (2011) 1.61

Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res (2008) 1.59

Immune influence on adult neural stem cell regulation and function. Neuron (2009) 1.59

Reduction of adult hippocampal neurogenesis confers vulnerability in an animal model of cocaine addiction. J Neurosci (2010) 1.59

Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J Biol Chem (2008) 1.59

Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry (2012) 1.57

Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci (2011) 1.55

Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci (2008) 1.55

The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology (2011) 1.52

Diminished adult neurogenesis in the marmoset brain precedes old age. Proc Natl Acad Sci U S A (2007) 1.52

Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci (2008) 1.49

Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci (2011) 1.48

Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress. Mol Psychiatry (2010) 1.47

An animal model of a behavioral intervention for depression. Neuron (2008) 1.46

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46

Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A (2008) 1.46

A new role for FGF2 as an endogenous inhibitor of anxiety. J Neurosci (2009) 1.45

Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One (2011) 1.45

Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos Trans R Soc Lond B Biol Sci (2006) 1.44

VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol (2007) 1.41

Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J Psychiatry Neurosci (2006) 1.41

Structural plasticity and hippocampal function. Annu Rev Psychol (2010) 1.40

The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol (2011) 1.39

Sleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats. J Physiol (2003) 1.39

Males and females respond differently to controllability and antidepressant treatment. Biol Psychiatry (2004) 1.38

Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci U S A (2010) 1.37

Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci U S A (2001) 1.37

Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry (2010) 1.36

The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology (2011) 1.36

Neuroscience. Is more neurogenesis always better? Science (2007) 1.36

Genetically increased cell-intrinsic excitability enhances neuronal integration into adult brain circuits. Neuron (2010) 1.35

Traumatic stress: effects on the brain. Dialogues Clin Neurosci (2006) 1.35

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci (2007) 1.34

GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder. Front Mol Neurosci (2012) 1.34

Development of proneurogenic, neuroprotective small molecules. J Am Chem Soc (2011) 1.33

p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus. Proc Natl Acad Sci U S A (2008) 1.31

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31

Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress. J Comp Neurol (2008) 1.30

The critical role of cyclin D2 in adult neurogenesis. J Cell Biol (2004) 1.30

Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology (2007) 1.29

Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One (2010) 1.29

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res (2008) 1.28

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl) (2009) 1.28

A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem (2010) 1.27

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res (2008) 1.26

Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis (2010) 1.26

13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci U S A (2004) 1.26

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry (2013) 1.26

Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol Psychiatry (2012) 1.25

Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology (2011) 1.25

Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months. Proc Natl Acad Sci U S A (2011) 1.25

Running is rewarding and antidepressive. Physiol Behav (2007) 1.25

All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis. Curr Top Behav Neurosci (2013) 1.25

The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.25

Articles by these authors

A molecular and cellular theory of depression. Arch Gen Psychiatry (1997) 6.10

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci (1995) 5.10

Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29

Regulation of cocaine reward by CREB. Science (1998) 4.07

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci (1996) 3.33

Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci (2001) 3.09

Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09

Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci (1997) 2.69

Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science (1996) 2.68

Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61

Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med (2000) 2.61

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53

Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A (1992) 2.49

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42

Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A (2000) 2.39

Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci (1999) 2.36

Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci (2001) 2.30

Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience (2003) 2.19

FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A (1997) 1.98

Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature (1998) 1.88

Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse (2008) 1.87

cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci (2000) 1.86

The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci (1997) 1.84

A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res (1991) 1.84

Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci (1996) 1.82

Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci (1996) 1.80

Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry (1996) 1.79

Determination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone. Neuroscience (2007) 1.75

Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci (1998) 1.70

Distribution of protein I in mammalian brain as determined by a detergent-based radioimmunoassay. Proc Natl Acad Sci U S A (1981) 1.70

Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain. Brain Res Mol Brain Res (2000) 1.62

Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci (1997) 1.62

Sensitization to morphine induced by viral-mediated gene transfer. Science (1997) 1.62

Protein phosphorylation in the brain. Nature (1983) 1.60

Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther (1995) 1.60

Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci (1995) 1.59

Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol (1998) 1.58

Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend (1998) 1.53

Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry (2001) 1.53

Dopamine and depolarizing agents regulate the state of phosphorylation of protein I in the mammalian superior cervical sympathetic ganglion. Proc Natl Acad Sci U S A (1980) 1.51

Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A (1996) 1.49

Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci (2002) 1.44

Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol (1995) 1.44

CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci (1997) 1.38

Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci (1999) 1.37

Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci (1995) 1.36

Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci (1990) 1.34

Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem (1990) 1.32

Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res (2003) 1.31

Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol (1996) 1.30

Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem (2001) 1.29

Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci (1997) 1.28

Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1. J Neurosci (2000) 1.28

Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther (1994) 1.28

Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse (1995) 1.27

Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett (1999) 1.27

Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res (1997) 1.26

Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res (1991) 1.26

Molecular mechanisms of psychostimulant-induced structural plasticity. Pharmacopsychiatry (2009) 1.25

Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol (2000) 1.24

Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci (1998) 1.24

Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther (1988) 1.23

Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull (2001) 1.22

Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience (2006) 1.21

Neuronal phosphoproteins: physiological and clinical implications. Science (1984) 1.21

Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci (1996) 1.20

Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem (1991) 1.20

Endogenous ADP-ribosylation in brain: initial characterization of substrate proteins. J Neurochem (1991) 1.20

Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience (1995) 1.19

5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci (1997) 1.19

Depresssion--emerging insights from neurobiology. Br Med Bull (2001) 1.18

Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology (1996) 1.18

Molecular and functional analysis of hyperpolarization-activated pacemaker channels in the hippocampus after entorhinal cortex lesion. FASEB J (2001) 1.15

Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron (2000) 1.14

Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience (1999) 1.14

Nerve impulses increase the phosphorylation state of protein I in rabbit superior cervical ganglion. Nature (1982) 1.13

Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem (1993) 1.13

Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biol Psychiatry (2001) 1.12

Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci (1998) 1.11

Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol (1996) 1.11

Resistance to change and vulnerability to stress: autistic-like features of GAP43-deficient mice. Genes Brain Behav (2010) 1.11

Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci (1992) 1.10

Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience (2006) 1.10

Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci (1999) 1.10

Rat LCR1: cloning and cellular distribution of a putative chemokine receptor in brain. Mol Psychiatry (1996) 1.09

Cellular and subcellular localization of protein I in the peripheral nervous system. Proc Natl Acad Sci U S A (1982) 1.09

ΔFosB in the nucleus accumbens is critical for reinforcing effects of sexual reward. Genes Brain Behav (2010) 1.09

Delta FosB overexpression in the nucleus accumbens enhances sexual reward in female Syrian hamsters. Genes Brain Behav (2009) 1.08

Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse (1999) 1.08